GLPwatch

Hypocalcemia secondary to hypomagnesemia in a patient on liraglutide.

Ann Med Surg (Lond) · 2020

Last updated 2026-08-28
JournalAnn Med Surg (Lond), 2020
Citations4
Relative citation ratio0.23
NIH percentile15
Molecules liraglutide

Abstract

A 73-year-old man with type 2 diabetes on Liraglutide with a history of coronary artery disease. Admitted to emergency for abdominal pain, severe diarrhea and episodes of tetany attacks. Laboratory workup reveals hypomagnesemia, hypocalcemia and normal parathormone (PTH). After intravenous administration of magnesium and calcium, the blood ionogram quickly normalized. In addition, plasma levels of intact parathyroid hormone increased immediately after magnesium administration. Strongly suggests that hypocalcemia resulted from a disruption of adequate parathyroid hormone secretion caused by hypomagnesemia which in turn was caused by severe diarrhea under treatment with Liraglutide.

Verbatim abstract via PubMed 33224484 ↗

Related research